Allergic Rhinitis
Conditions
Interventions
The Respiratory Allergy Optimiser
Sponsors
General Practitioners Research Institute
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Aged = 18 years.One of the following:Diagnosis of allergic rhinitis (ICPC R97), or allergic conjunctivitis (F71)Prescribed with medication for allergic rhinitis in the previous 3 year, with one of the following medication groups (ATC23 codes): R01AA, R01AB, R01AC, R01AD, R01AX, R06AE, R06AX, S01BA, S01GX, H02A or H02B.Capacity to understand and provide written informed consent.
Exclusion criteria
Exclusion criteria: Patients participating in an interventional clinical trial for allergic diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The difference between pre-intervention and post-intervention allergic rhinitis symptom severity as measured by a visual analogue scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| The proportion of patients whose pharmacological management at pre-intervention aligns with the guideline-based pharmacological management suggestions that are pertinent to their disease severity, either:The proportion of patients that received “continue” advice from the Respiratory Allergy Optimiser.The proportion of patients that received “step-up” advice from the Respiratory Allergy Optimiser.The proportion of patients that received “step-down” advice from the Respiratory Allergy Optimiser.The proportion of patients that received “consider initiation of Allergy Immune Therapy (AIT)” advice from the Respiratory Allergy Optimiser.ExploratoryThe number of times that each specific guideline-based management suggestion for optimizing allergic rhinitis pharmacological management is advised by the Respiratory Allergy Optimiser.Healthcare providers: the usability, the likelihood to follow-up on pharmacological management suggestions and likelihood to continue the use of the Respiratory Allergy Optimiser in the future. Patients: experience during the AERO visit in comparison with other previous clinical visits. | — |
Countries
Netherlands
Contacts
Public ContactAERO Team
General Practitioners Research Institute
Outcome results
None listed